Preface |
|
ix | |
Contributors |
|
xi | |
|
1 Ecotoxicity Test Methods for Endocrine-Disrupting Chemicals: An Introduction |
|
|
1 | (6) |
|
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (2) |
|
1.5 Testing Schemes for EDCs |
|
|
5 | (2) |
|
|
6 | (1) |
|
2 Endocrine Disruption in Wildlife: Background, Effects, and Implications |
|
|
7 | (52) |
|
|
|
2.1 Background to Endocrine Disruption |
|
|
8 | (11) |
|
2.2 Effects of EDCs on Wildlife |
|
|
19 | (13) |
|
2.3 Weight of Evidence and Ecological Significance of ED Effects |
|
|
32 | (4) |
|
2.4 Implications for Effect Assessment and Toxicity Testing |
|
|
36 | (2) |
|
2.5 Need for More Field Studies and an Integrated Approach |
|
|
38 | (1) |
|
|
39 | (20) |
|
|
40 | (19) |
|
3 The Regulatory Need for Tests to Detect EDCs and Assess Their Hazards to Wildlife |
|
|
59 | (41) |
|
Hans-Christian Stolzenberg |
|
|
|
|
|
|
|
|
|
3.1 Emerging Concerns and Policy Responses: Focusing on EDCs as a Large Pseudo-Uniform Group of Substances |
|
|
60 | (20) |
|
3.2 General Approaches in Substance-Related Regulatory Frameworks (EU) |
|
|
80 | (7) |
|
3.3 How to Make EDC Definitions Operational for Substance-Related Regulatory Work |
|
|
87 | (4) |
|
|
91 | (1) |
|
|
92 | (8) |
|
|
93 | (7) |
|
4 Techniques for Measuring Endocrine Disruption in Insects |
|
|
100 | (16) |
|
|
|
100 | (5) |
|
|
105 | (3) |
|
|
108 | (2) |
|
|
110 | (1) |
|
|
110 | (6) |
|
|
110 | (6) |
|
|
116 | (27) |
|
|
|
116 | (2) |
|
5.2 Background to Crustacean Endocrinology |
|
|
118 | (3) |
|
5.3 State of the Art: What Do We Know About Endocrine Disruption in Crustaceans? |
|
|
121 | (7) |
|
5.4 Available Subchronic/Chronic Standard Test Protocols |
|
|
128 | (1) |
|
5.5 Complementary Tools for Identification of Endocrine Disruption |
|
|
129 | (3) |
|
5.6 Summary and Conclusions |
|
|
132 | (11) |
|
|
134 | (9) |
|
6 Endocrine Disruption in Molluscs: Processes and Testing |
|
|
143 | (42) |
|
Patricia D. McClellan-Green |
|
|
6.1 Background and Introduction |
|
|
143 | (2) |
|
6.2 What Constitutes the Endocrine System in Molluscs? |
|
|
145 | (9) |
|
6.3 End Points and Biomarkers of Endocrine Disruption |
|
|
154 | (10) |
|
6.4 Current Test Methods Using Molluscs |
|
|
164 | (3) |
|
6.5 Proposed Test Methods |
|
|
167 | (4) |
|
|
171 | (14) |
|
|
172 | (13) |
|
7 Using Fish to Detect Endocrine Disrupters and Assess Their Potential Environmental Hazards |
|
|
185 | (17) |
|
|
|
185 | (3) |
|
7.2 International Efforts to Standardize Fish-Based Methods for Screening and Testing Endocrine-Disrupting Chemicals |
|
|
188 | (1) |
|
7.3 Fish-Based Screens Developed by OECD for Endocrine-Disrupting Chemicals |
|
|
189 | (5) |
|
7.4 Progress with Developing Fish Partial Life Cycle Tests for Endocrine Disrupters |
|
|
194 | (1) |
|
7.5 Prospects for the Standardization of Fish Full Life Cycle and Multigeneration Tests |
|
|
195 | (2) |
|
7.6 Strengths and Weaknesses of a Hazard Evaluation Strategy Based Partly on Available and Proposed Fish Screens and Tests |
|
|
197 | (1) |
|
|
198 | (4) |
|
|
198 | (4) |
|
8 Screening and Testing for Endocrine-Disrupting Chemicals in Amphibian Models |
|
|
202 | (43) |
|
|
|
202 | (1) |
|
8.2 Potential Uses of Amphibians in Endocrine Disrupter Screening and Testing Programs |
|
|
203 | (2) |
|
8.3 Embryonic Development |
|
|
205 | (3) |
|
|
208 | (1) |
|
|
209 | (15) |
|
8.6 Higher-Tier Tests with Amphibians |
|
|
224 | (3) |
|
8.7 Other and Emerging Test Methods |
|
|
227 | (2) |
|
8.8 Summary and Conclusions |
|
|
229 | (16) |
|
|
232 | (13) |
|
9 Endocrine Disruption and Reptiles: Using the Unique Attributes of Temperature-Dependent Sex Determination to Assess Impacts |
|
|
245 | (27) |
|
|
|
|
245 | (7) |
|
9.2 Approaches to Examine Effects of EDCs |
|
|
252 | (3) |
|
9.3 Induction of Sex Reversal In Ovo |
|
|
255 | (5) |
|
9.4 Analysis of Sex-Reversed Animals |
|
|
260 | (5) |
|
|
265 | (7) |
|
|
266 | (6) |
|
|
272 | (32) |
|
|
|
|
|
|
272 | (3) |
|
10.2 Differences Between Birds and Mammals and Among Bird Species |
|
|
275 | (3) |
|
|
278 | (2) |
|
10.4 Studies with Embryos |
|
|
280 | (1) |
|
|
280 | (5) |
|
10.6 Examples of EDC Effects from Field Studies |
|
|
285 | (3) |
|
10.7 Proposed Two-Generation Test |
|
|
288 | (3) |
|
|
291 | (13) |
|
|
292 | (12) |
|
11 Mammalian Methods for Detecting and Assessing Endocrine-Active Compounds |
|
|
304 | (37) |
|
|
|
304 | (2) |
|
11.2 Mammalian Tier 1 Screening Assays |
|
|
306 | (20) |
|
|
326 | (3) |
|
11.4 Human and Wildlife Relevance of Estrogen, Androgen, and Thyroid Screening Assays |
|
|
329 | (1) |
|
11.5 Potential Future Assays for Endocrine Screening |
|
|
330 | (11) |
|
|
332 | (9) |
|
12 Application of the OECD Conceptual Framework for Assessing the Human Health and Ecological Effects of Endocrine Disrupters |
|
|
341 | (32) |
|
|
|
|
|
342 | (1) |
|
12.2 Overview of the OECD Revised CF |
|
|
343 | (3) |
|
12.3 Application of the Klimisch Criteria to the EE2 and VIN Case Studies |
|
|
346 | (1) |
|
12.4 Case Study: Data Examples for 17α-Ethynylestradiol |
|
|
346 | (11) |
|
12.5 Case Study: Data Examples for Vinclozolin |
|
|
357 | (10) |
|
|
367 | (6) |
|
|
368 | (5) |
|
13 The Prospects for Routine Testing of Chemicals for Endocrine-Disrupting Properties and Potential Ecological Impacts |
|
|
373 | (12) |
|
|
|
373 | (1) |
|
13.2 Are There Gaps in the Test Suite for EDCs? |
|
|
374 | (2) |
|
13.3 "New" Modes of Endocrine-Disrupting Action |
|
|
376 | (1) |
|
13.4 How Should Tests for EDCs Be Deployed in an Integrated Fashion? |
|
|
377 | (3) |
|
13.5 Use of Weight of Evidence when Assessing Possible EDCs |
|
|
380 | (2) |
|
|
382 | (3) |
|
|
382 | (3) |
Index |
|
385 | |